Table 1.
List of reports and the corresponding data sources.
Name | Data source |
---|---|
1. Federal reports | |
Number of tested samples and percent positive for COVID-19 (grouped by age) | CP-LIS |
Number of tested samples and percent positive | CP-LIS |
The overall percentage of patient visits for ILI | Epic (AOE) |
Associated factors with hospitalizations: | Epic (admission report) |
– By age | |
– By sex | |
– Age-adjusted COVID-19-associated hospitalization rates by race and ethnicity | |
2. State reports | |
Viral testing (positive, negative, total) by patient zip code/county | CP-LIS |
Heat map [Fig. 4] | CP-LIS |
3. Laboratory operational reports | |
3.1 Performance metrics | |
Cumulative COVID-19 tests ordered (number, percent) result breakdown | CP-LIS |
Cumulative antibody test (number, percent) results breakdown | CP-LIS |
Percent results reported within target TAT, average, and range of TAT [Fig. 6] | CP-LIS |
Average number of total tests resulted by the hour | CP-LIS |
Resulted tests grouped by average TAT [Fig. 7] | CP-LIS |
3.2 Technician performance assessment | |
Number of the test resulted by each technician | CP-LIS |
Average number of the test resulted per technician per hour compared with received tests per hour | CP-LIS |
3.3 Analyzer metrics | |
Batch size and frequency of viral testing vs. TAT (measured for Roche) [Fig. 8] | CP-LIS |
Batch size and frequency of viral testing vs. TAT (measured for Cepheid) | CP-LIS |
Batch size and frequency of antibody testing vs. TAT | CP-LIS |
4. Clinical reports | |
Antibody testing numbers, breakdown of results, and titer of antibodies | CP-LIS |
List of eligible antibody donors | CP-LIS |
Number of total transfusions | |
5. Research reports | CP-LIS |
List of pregnant patients with positive viral testing | Epic |
Number of patients with prior positive viral testing with first negative viral testing grouped by duration [Fig. 9] | CP-LIS |
Number of patients with positive viral testing with first antibody-positive test vs. days [Fig. 10] | CP-LIS |